Here, we demonstrate that targeting highly amplified regions within the genome, such as MYCN in neuroblastoma cells, with the RuvC mutant SpyCas9D10A nickase affords an opportunity to exploit genomic vulnerabilities to induce cell death in a gene amplification-dependent manner. Here, MYCN is linked to neuroblastoma.